Zhongshan Kangtian Shenghe Biotechnology Co., Ltd
Zhongshan Kangtian Shenghe Biotechnology Co., Ltd. (referred to as "Kangsheng Biotechnology")Overseas ReturneesFounded in April 2018 by Dr. Pan Honghui and several other experts, [2] settled inZhongshan National Health Science and Technology Industry Base——Zhongde (Zhongshan) Biomedical Industry Park is a company that integrates research and development, production, and servicesinternationalizationBiotechnologyThe company. [4] Its core product is applied to proteinsMonoclonal antibodyMedicationsvaccinesDrug development and productionSerum-free culture medium, including chemically restricted culture media, non animal derived culture media [1], and commercially authorizedCHO cellsZhu Development Platform [5].
Share
Recommended Posts
-
According to the World Health Organization, 90% of people worldwide breathe polluted air every day. Air pollution causes 7 million premature deaths annually due to diseases such as cancer, stroke, heart disease, and lung disease. 90% of premature deaths occur in low - to middle-income countries with high emissions of industrial, transportation, and agricultural pollutants. -
Recently, a landmark study on neural cells was published, in which researchers claimed to have discovered that brain neurons can modify their own DNA on their own. For a long time, the biomedical community has believed that human somatic DNA is fixed. According to Science, the discovery that "brain cells can modify their own DNA" has been evaluated as "possibly one of the major discoveries in the field of molecular biology in recent years". Researchers analyzed the donated brains of 6 healthy elderly individuals and 7 non secondary Alzheimer's disease patients and found that patients with Alzheimer's disease carry six times more APP variant gene varieties in their neuronal cells than the general population. Therefore, researchers speculate that the ability of brain cells to modify DNA on their own may contribute to the development of Alzheimer's disease.
-
Under the trend of domestic substitution in the medical device industry, the drive to explore overseas markets is also increasing. Going global is the key for the medical device industry to seek new growth curves and enhance international competitiveness.Moreover, China is implementing a more proactive opening-up strategy. Jointly building the "the Belt and Road" has become a popular international public product and international cooperation platform to achieve higher quality and deeper mutual benefit and win-win results with countries along the line.
